Archive

Posts Tagged ‘LUNG’

Video On Planet Earth: Preserve the Pulmonary Atmosphere!

13 de julho de 2012 Comentários desligados

Video On Planet Earth: Preserve the Pulmonary Atmosphere!

@PulmaSA presents a video about your home: planet earth. However this video from NASA where they observe the Earth’s atmosphere at various times, including images of the aurora borealis, serves to remind us of the air we inhale into our lungs, and how we should preserve it. This is also the site of our mission: Inform them so they can protect their real atmosphere, the air in the lung.

After all: @PulmaoSA means: Lungs – Your atmosphere, Your Life!®

Delight and share the video below!

Welcome, and remember: Do not Smoke! Especially around children!

PulmaoSA Pulmonology’s Pearls 1

13 de junho de 2012 Comentários desligados

PulmaoSA Pulmonology’s Pearls 1 Occam’s Razor over Saint’s Triad

The @PulmaoSA is pleased to inaugurate with this post a series named Pulmonology Pearls with discussions whose the goals are:

  • Increasing the Health Professional Culture with a CHPE ( Continuous Health Professional Education);
  • Stimulate multiprofessional discussion about respiratory diseases and
  •  Benefit the patients with respiratory diseases.

Thus Physiotherapists, Nurses, Doctors and medical students and other students from health areas are invited to collaborate. The article will be posted here at PulmaoSA website, but the discussions will happen at  PulmaoSA Group in Facebook.
The discussions could be done in Portuguese and also in English.

So, Be Very Welcome!

The first article may be downloaded from the link below:

Occam’s Razor over Saint’s Triad

Sources:

@PulmaoSA – Lungs: Your Real Atmosphere: Your Life! ®

NEJM

PD em pneumologia / Post doc in Pulmonology

10 de junho de 2012 Comentários desligados

20120610-113622 AM.jpg

PD em pneumologia com Bolsa da FAPESP

Agência FAPESP – O Projeto Temático “Avaliação da musculatura ventilatória ins e expiratória nas doenças respiratórias”, apoiado pela FAPESP, oferece uma oportunidade de Bolsa de Pós-Doutorado com duração de 24 meses.

O candidato deve ter: doutoramento concluído há menos de sete anos; experiência com medidas de mecânica ventilatória e fisiologia respiratória; experiência com avaliações das respostas fisiológicas pulmonares ao esforço; experiência de pelo menos um ano em um centro internacional.

O candidato fará parte de um estudo específico da mecânica ventilatória nos pacientes com paralisia diafragmática, envolvendo medidas de pressão transdiafragmática, eletromiografia de superfície e estimulação magnética.

O candidato interessado e que preencha os requisitos em questão deverá enviar currículo atualizado para o professor Carlos Carvalho (crrcarvalho@uol.com.br), no Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, até o dia 15 de outubro de 2011.

Plano de trabalho da Bolsa de Pós-Doutorado: http://www.fapesp.br/oportunidades/op244.pdf

A vaga está aberta a brasileiros e estrangeiros. O selecionado receberá Bolsa de Pós-Doutorado da FAPESP (no valor de R$ 5.333,40 mensais), Reserva Técnica e Auxílio-Instalação. A Reserva Técnica de Bolsa de PD equivale a 15% do valor anual da bolsa e tem o objetivo de atender a despesas imprevistas e diretamente relacionadas à atividade de pesquisa.

Fonte:

@PulmaoSA News

Latest News in Copd

7 de junho de 2012 Comentários desligados

20120607-041757 PM.jpg

Latest News in COPD: Olodaterol

(PulmaoSANews) The COPD patients will count with a new possibility to treat this disease that is popular known as crhonic bronchitis or pulmonary emphisema. The US Boehringer announced that the phase ll study with a drug named olodaterol, a long-acting ß 2-agonist (LABA) showed a significant imcrease in lung function of chronic obstructive pulmonary disease (COPD) patients, delivered via the Respimat ® Inhaler.
What does it really means?
It means that COPD patients will count with another option besides Indacaterol (Onbrize ) to decrease their symptoms and make better their quality of life.
Phase ll Study
In this Phase II randomized, double-blind, cross-over study,
olodaterol administered QD as 5 µg or 10 µg provided a significant and identical increase in the lung function parameter FEV 1 over a 24-hour period. This data completes the olodaterol monotherapy Phase II clinical trial program in patients with COPD.

Sources:

PulmaoSA

<a

<img src=

How many years Smoking Ages You?

17 de abril de 2012 Comentários desligados

How many years Smoking Ages You?

 

Watch the @Pulmaosa video and answer yourself that smoking is an old bad idea:

 

What MDs and Nurse Practioners Need to know About Lung Cancer

15 de abril de 2012 Comentários desligados

What MDs and Nurse Practioners Need to know About Lung Cancer

<div style=”width:425px” id=”__ss_12550194″> <strong style=”display:block;margin:12px 0 4px”><a href=”http://www.slideshare.net/PulmaosaPulmao/lung-cancer-what-medicine-and-nurses-should-know&#8221; title=”Lung Cancer: what MDs and Nurses Need to know” target=”_blank”>Lung Cancer: what MDs and Nurses Need to know</a></strong> <div style=”padding:5px 0 12px”> View more <a href=”http://www.slideshare.net/thecroaker/death-by-powerpoint&#8221; target=”_blank”>PowerPoint</a> from <a href=”http://www.slideshare.net/PulmaosaPulmao&#8221; target=”_blank”>Pulmaosa Pulmao</a> </div> </div>

Follow @PulmaoSA no Twitter

In terms of public health and tobacco prevention: Enough is just enough!

19 de março de 2012 Comentários desligados

Enough is enough

Marcos Nascimento, MD.

In addressing the tobacco control policies that promote smoking cessation, we can separate them into two groups:

a) Public Health Approaches: are increasing attempts to stop smoking:

  • Increased taxation;
  • Regulations to restrict smoking in public places and workplaces;
  • The Campaign of mass media.

b) Approach in Healthcare: increased rates of smoking cessation:

  • Help / Treatment Smokers.

Evidently tobacco addiction is a multidimensional phenomenon. Thus a proper treatment should include dimensions beyond pharmacological while also addressing the issues of psychological and behavioral addiction. Tell that to treat smokers just put drugs in the pharmacy is a popular reductionism overwhelming.

From the perspective of public health strategies we have to be more cost-effective. If a country have little money, it naturally must to select priorities within the priorities and see which option expense is the best. Of all the strategies listed the most cost-effective policies are smoke free environments.

The countries who are enrolling in a upward trend in the prevalence of tobacco related diseases like lung cancer, cardio vascular diseases and COPD, etc, can not afford to lose the way in terms of tobacco control. Some countries like Australia, Canada, Uruguay and Brazil are giving good examples about tobacco control and Pulbic Health issues.

In order to draw the attention of managers of public and private health for the cause, I have recently published in this website an article titled “The Smoking math formula: ” Smoking = COPD + P
ie., smoking is a generator of Cardiac, Oncologic, Pulmonary Diseases + Pediatric and calls attention to COPD, a disease underdiagnosed with high personal and economic impacts which are now the 3rd death cause in US.

Thus didactical formula Indicates the need for an early & all-embracing approach to smoking because it generates 52 other diseses and produces a huge financial resources scrap, including reducing the productivity of businesses – And just like the tobacco disease, the finance costs are also preventable. Thus the necessity to  early involve children and young people in prevention education with the creation of aplications (Apps), games and cartoons, as proposed in the “children’s story Zoo Logic?”

We can justify, rationalize, and pontificate about individual freedom all we want, but in the tobacco prevention there is “the role of nicotine,” that imposes a high and uncontrolled addiction, and if we go for this process, we will stick our heads in the sand.

The reality is cruel because millions of people are suffering and dying unnecessarily every day. We have the collective means to do something about it with minimal personal sacrifice. Thus, we can keep walking and trying to solve the problem accepting the necessity of public smoke free environments.

In fact, we achieved some important gains in preventing smoking-related diseases in the latest years.  But in terms of public health: Enough can be just enough!

Mainly, because the Life is in the game!

So, Enough is enough. It’s time to step up!

With All Respect,
Marcos Nascimento,MD
Medicine Professor
http://twitter.com/PulmaoSA

%d blogueiros gostam disto: